Working… Menu
Trial record 37 of 52 for:    LENALIDOMIDE AND Leukemia AND Acute Myeloid Leukemia

CPX-351+GO in Subjects 55 Years Old, or Older, With AML (CPX GO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03878927
Recruitment Status : Recruiting
First Posted : March 18, 2019
Last Update Posted : September 17, 2019
Jazz Pharmaceuticals
Information provided by (Responsible Party):
Weill Medical College of Cornell University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 25, 2021
Estimated Study Completion Date : August 25, 2026